In this paper the authors report on the 2-year results of the randomized US pivotal trial for surgical and self-expanding percutaneous aortic prosthetic valves. The survival benefit observed at 1 year in the transcatheter group were sustained at two years.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
TAVR (TAVI)
June 17, 2015
June 14, 2015
In this manuscript the authors report on data from the German Aortic Valve Registry (GARY) comprising 15964 transcatheter aortic valve replacement (TAVR) procedures performed from 2011 to 2013 evaluating severe vital complications (SVCs), technical complications of the procedures (TCOs), other complications, conversion to sternotomy and in-hospital d
June 13, 2015
In this open-access article, the authors describe their findings in a systematic review of transcatheter heart valve (THV) failures, comprising 70 articles and 87 individual cases. Unusual complications such as late embolization (mostly into the left ventricle) and prosthetic compression (exclusively in balloon expandable THVs) are described.
May 21, 2015
In March 2015, the first successful transcatheter aortic valve replacement (TAVR) was performed at the Armed Forces Institute of Cardiology (AFIC) in Rawalpindi, Pakistan. In this interview, recorded via Google Hangouts, Joel Dunning talks with Atiq Rehman of Lourdes Health System, NJ, and Kamran Baig of Trent Cardiac Centre,UK, about this development.
May 14, 2015
In this manuscript the authors describe their findings in an observational study of patients undergoing either aortic valve replacement with a “sutureless” aortic valve bioprosthesis (Medtronic’s 3f Enable) or transcatheter aortic valve implantation (TAVI) with either an Edwards Sapiens XT or Medtronic CoreValve prosthesis, comparing functional and c
April 24, 2015
In this manuscript the authors describe a systematic review of 71 cases of transcatheter heart valve embolization. In 72% of the patients, the prosthesis used was a balloon expandable one. In most cases valve embolization occurred soon after implantation and it happened in the aortic direction.
March 28, 2015
In a prospective study using MRI before and within 14 days after AVR and TAVI, Crouch and co-authors demonstrated that postoperative aortic regurgitation that was higher in the TAVI group had a significant impact on increasing left atrial size and declining right ventricular function.
March 21, 2015
The authors describe the one-year results of a randomized trial comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among an all-comers cohort of 280 patients.
March 16, 2015
Using STS/ACC registry data, the authors updated 30-day outcomes and present 1 year outcomes for TAVR pts. Over 12,000 pts were in the registry; median age was 84, and STS predicted operative mortality risk was 7.1%. 30-day mortality was 7.0%, 1-year mortality was 23.7%. 1-year mortality was associated with advanced age, male sex, end-stage renal
March 6, 2015
This video demonstrates a transaortic approach for TAVR, through the second intercostal space. Illustrations, photos, 3D CAT scan images, and rotating fluoroscopic images are used to demonstrate this approach.